title: Rationale of combined PDT and SDT modalities for treating cancer patients in terminal stage: the proper use of photosensitizer.
authors.affiliation: Department of Radiation Oncology, AMC Cancer Center, University of Colorado–Denver, 1600 Pierce Street, Denver, CO 80214, USA. zheng_huang@msn.com
authors.forename: Zheng
authors.initials: Z
authors.lastname: Huang
authors.forename: Harry
authors.initials: H
authors.lastname: Moseley
authors.forename: Stephen
authors.initials: S
authors.lastname: Bown
mesh_terms: D003131:Combined Modality Therapy / Q000379:methods / Q000706:statistics & numerical data; D006801:Humans; D009367:Neoplasm Staging; D009369:Neoplasms / Q000473:pathology / Q000628:therapy*; D010778:Photochemotherapy / Q000379:methods / Q000706:statistics & numerical data; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011908:Rationalization; D016879:Salvage Therapy / Q000379:methods; D013727:Terminal Care / Q000379:methods; D014464:Ultrasonic Therapy / Q000379:methods / Q000706:statistics & numerical data
chemical_list: D017319:Photosensitizing Agents